Faron, etusivu

releases and announcements

Faron Licenses Traumakine Rights to Pharmbio Korea

Regulatory

Faron Result of Annual General Meeting

Regulatory

Faron Expands R&D Strategy for Clevegen

Regulatory

Faron Pharmaceuticals Ltd to host an R&D Day

Regulatory

Notice of AGM

Regulatory

Faron Appoints New Medical Director

Regulatory

Faron Appoints Panmure Gordon as Joint Broker

Regulatory

Faron Files Two New Patents to Protect Clevegen

Regulatory

Annual Results for the year ended 31 December 2015

Regulatory

Faron files patent application for Traumakine

Regulatory
PreviousNext
Back to top